Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Clinical trial NCT01324232 · COMPLETED
Trial details
- NCT number
- NCT01324232
- Sponsor
- Avanir Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-08
- Primary completion
- 2013-09-26
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.